Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Oral (Rat, GLP): LD50 > 2000 mg/kg
[Schering AG, Report No. A860, 1994-01-12]
Dermal (Rat, GLP): LD50 > 2000 mg/kg
[Schering AG, Report No. X192, 1997-01-08]

Key value for chemical safety assessment

Additional information

The single oral administration of the test substance (ZK 39211) to male and female rats at a dose of 2000 mg/kg was tolerated without any compound-related clinical or macroscopic pathological signs. The acute oral toxicity of ZK 39211 in rats is above 2000 mg/kg body weight. (Schering AG, Report No. A860, 1994-01-12)

The single dermal administration of Tamip monoamide to male and female rats in the doses of 200 and 2000 mg/kg results at high dose in clinical signs (retarded respiration, gasping breathing, eyelid closure, unconsciousness in 1/3 male rats; apathy 2/3 male rats). One male rat died. The female animals were without any clinical signs. LD50 > 2000 mg/kg (Schering AG, Report No. X192, 1997-01-08)

Justification for classification or non-classification

For oral and dermal administration classification according to Directive 67/548/EEC and Regulation 1272/2008/EC is not required since LD50 <2000 mg/kg.